Efficacy of NVA237 Compared to Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Status:
Completed
Trial end date:
2014-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to further figure out differences of glycopyrronium bromide
compared to tiotropium in early bronchodilation measured by a comprehensive assessment of
lung function that includes hyperinflation and specific airway resistance in patients with
moderate to severe COPD.